NRx Pharmaceuticals' stock jumps following new analysis of its potential Covid-19 drug

A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.